Optimizerx Corporation (OPRX) – Company Press Releases
-
OptimizeRx Releases 2024 Environmental, Social, and Governance (ESG) Report
-
OptimizeRx Reports Strong Fourth Quarter and Full Year 2023 Financial Results
-
OptimizeRx Named America’s Fastest-Growing Company for Fifth Year in a Row
-
OptimizeRx Sets Fourth Quarter 2023 Conference Call for March 28, 2024 at 8:30 a.m. ET
-
OptimizeRx Provides an Update on the Timing of Earnings Call and Reaffirms Prior Revenue and Adjusted EBITDA Estimates for FY2023
-
OptimizeRx Powers Walmart's ‘Specialty Pharmacies of the Community’ Outreach Effort
-
OptimizeRx Powers Walmart's ‘Specialty Pharmacies of the Community’ Outreach Effort
-
OptimizeRx to Participate in Upcoming Investor Conferences
-
OptimizeRx Announces Strategic Board Changes to Support Growth and Evolving Landscape
-
OptimizeRx Preannounces Select Expected 2023 Financials and Provides a Business Update
-
OptimizeRx to Participate at the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco
-
OptimizeRx Reports Third Quarter 2023 Financial Results
-
OptimizeRx Announces Completion of Medicx Acquisition and Sets Third Quarter 2023 Conference Call for November 6, 2023, at 8:30 a.m. ET
-
OptimizeRx Announces Agreement to Acquire Medicx Health for $95 million to Expand its Omnichannel Reach to Consumers
-
OptimizeRx Unveils a Significant Enhancement to its Omni-channel Healthcare Engagement Platform
-
OptimizeRx Expands AI Powered Omnichannel Platform
-
OptimizeRx Reports Second Quarter 2023 Financial Results
-
Milestone: Socialsuite Empowers 100 Small-Mid Cap Companies to Easily Adopt ESG With Affordable Solution
-
OptimizeRx Sets Second Quarter 2023 Conference Call for August 14, 2023 at 4:30 p.m. ET
-
LifeMD Appoints William J. Febbo to its Board of Directors
-
OptimizeRx’s CEO Provides 2023 Midyear Strategic Update
-
OptimizeRx’s Karina Castagna Named One of the 2023 PM360 ELITE 100
-
OptimizeRx to Participate in Upcoming Investor Conferences
-
OptimizeRx Reports First Quarter 2023 Financial Results
-
Surveyed Physicians Spell Out Preferences for Data-driven, Omnichannel Content That Delivers Clinical Relevance
-
Surveyed Physicians Spell Out Preferences for Data-driven, Omnichannel Content That Delivers Clinical Relevance
-
OptimizeRx Sets First Quarter 2023 Conference Call for May 10, 2023at 4:30 p.m. ET
-
OptimizeRx Sets First Quarter 2023 Conference Call for May 10, 2023at 4:30 p.m. ET
-
OptimizeRx Releases 2023 Environmental, Social and Governance (ESG) Report
-
OptimizeRx Releases 2023 Environmental, Social and Governance (ESG) Report
-
Financial Times Ranks OptimizeRx Amongst The Americas’ Fastest Growing Companies for the Fourth Consecutive Year
-
Financial Times Ranks OptimizeRx Amongst The Americas’ Fastest Growing Companies for the Fourth Consecutive Year
-
OptimizeRx Authorizes $15 Million Share Repurchase Program
-
OptimizeRx Authorizes $15 Million Share Repurchase Program
-
OptimizeRx Announces Multi-Year Agreement with Top Hub Services Provider to Accelerate Access for Patients
-
OptimizeRx Announces Multi-Year Agreement with Top Hub Services Provider to Accelerate Access for Patients
-
OptimizeRx Reports Fourth Quarter and Full Year 2022 Financial Results
-
OptimizeRx Reports Fourth Quarter and Full Year 2022 Financial Results
-
Fair Isaac & Co. Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600
-
OptimizeRx Sets Fourth Quarter & Fiscal Year 2022 Conference Call for March 8, 2023 at 4:30 p.m. ET
-
OptimizeRx Sets Fourth Quarter & Fiscal Year 2022 Conference Call for March 8, 2023 at 4:30 p.m. ET
-
OptimizeRx’s Karina Castagna Named to MM+M’s 40 Under 40 List of the Medical Marketing Industry’s Brightest Young Stars
-
OptimizeRx’s Karina Castagna Named to MM+M’s 40 Under 40 List of the Medical Marketing Industry’s Brightest Young Stars
-
OptimizeRx CEO Issues Open Letter to Shareholders Ahead of Presentation at J.P. Morgan Healthcare Conference
-
OptimizeRx CEO Issues Open Letter to Shareholders Ahead of Presentation at J.P. Morgan Healthcare Conference
-
OptimizeRx to Participate in Upcoming Investor Conferences
-
OptimizeRx to Participate in Upcoming Investor Conferences
-
OptimizeRx Reports Third Quarter 2022 Financial Results
-
OptimizeRx Reports Third Quarter 2022 Financial Results
-
OptimizeRx and Melinta Therapeutics Present Third Annual Innovate4Outcomes(R) Healthcare Design Thinking-Inspired Event
Back to OPRX Stock Lookup
